apomorphine has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chavez-Blanco, A; Correa-Basurto, J; Dominguez-Gomez, G; Duenas-Gonzalez, A; Garcia-Martinez, E; Gonzalez-Fierro, A; Romo-Perez, A; Taja-Chayeb, L | 1 |
| Auffret, M; Drapier, S; Vérin, M | 1 |
| Auld, DS; Boxer, MB; Ferraris, DV; Rojas, C; Shen, M; Simeonov, A; Slusher, BS; Tanega, C; Thomas, AG; Tsukamoto, T | 1 |
| Chen, ZF; Geng, B; Huang, KB; Liang, H; Liu, YC; Shi, YF | 1 |
| Chen, ZF; Jiang, YH; Khan, TM; Li, ZQ; Liang, H; Liu, YC; Qin, JL; Shen, WY; Wang, M; Wei, JH | 1 |
| Chen, ZF; Geng, B; Hong, X; Liang, H; Liu, YC; Peng, Y; Shi, YF | 1 |
| Martres, MP; Riou, JF; Schwartz, JC; Sokoloff, P | 1 |
1 review(s) available for apomorphine and Neoplasms
| Article | Year |
|---|---|
New tricks for an old dog: A repurposing approach of apomorphine.
Topics: Animals; Apomorphine; Dopamine Agonists; Drug Repositioning; Humans; Neoplasms; Nervous System Diseases; Sexual Dysfunction, Physiological | 2019 |
7 other study(ies) available for apomorphine and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal.
Topics: Apomorphine; Benserazide; Drug Combinations; Humans; Neoplasms; Pantoprazole; Simvastatin; Trimetazidine | 2022 |
Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors.
Topics: AIDS Dementia Complex; Apomorphine; Azoles; Benzophenanthridines; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Glutaminase; Humans; Inhibitory Concentration 50; Isoindoles; Neoplasms; Organoselenium Compounds; RNA, Small Interfering; Sensitivity and Specificity | 2013 |
Oxoglaucine-lanthanide complexes: synthesis, crystal structure and cytotoxicity.
Topics: Apomorphine; Apoptosis; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Lanthanoid Series Elements; Models, Molecular; Neoplasms; Tumor Cells, Cultured | 2014 |
Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.
Topics: Animals; Antineoplastic Agents; Apomorphine; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; DNA Damage; Dysprosium; Humans; Medicine, Chinese Traditional; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2; S Phase; Solubility; Topoisomerase Inhibitors; Tumor Burden; Water; X-Ray Diffraction; Yttrium | 2015 |
TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apomorphine; Cattle; Cell Cycle; Cell Line; Coordination Complexes; Crystallography, X-Ray; DNA; DNA Topoisomerases, Type I; Drugs, Chinese Herbal; Humans; Models, Molecular; Neoplasms; Topoisomerase I Inhibitors; Transition Elements | 2012 |
Presence of dopamine D-2 receptors in human tumoral cell lines.
Topics: Apomorphine; Breast Neoplasms; Cell Membrane; Digestive System Neoplasms; Dopamine; Humans; Iodine Radioisotopes; Leukemia; Lung Neoplasms; Neoplasms; Neuroblastoma; Phenethylamines; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride; Tumor Cells, Cultured | 1989 |